Be a Smart Investor
Wednesday, May 1, 2019
Evelo Biosciences: What's The Near-term Catalyst?
The clinical trial results of a drug company can impact its stock price depending upon the outcome - and more so if it is a small-/mid-cap biopharma stock.
from RTT - Biotech http://bit.ly/2V7XzRh
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment